Agency of the United States Department of Health and Human Services
POPULARITY
Categories
357 episodes with fda
281 episodes with fda
183 episodes with fda
247 episodes with fda
229 episodes with fda
126 episodes with fda
183 episodes with fda
112 episodes with fda
147 episodes with fda
150 episodes with fda
273 episodes with fda
183 episodes with fda
178 episodes with fda
185 episodes with fda
53 episodes with fda
82 episodes with fda
75 episodes with fda
90 episodes with fda
65 episodes with fda
62 episodes with fda
135 episodes with fda
55 episodes with fda
70 episodes with fda
107 episodes with fda
107 episodes with fda
61 episodes with fda
68 episodes with fda
36 episodes with fda
96 episodes with fda
44 episodes with fda
50 episodes with fda
65 episodes with fda
44 episodes with fda
42 episodes with fda
105 episodes with fda
43 episodes with fda
64 episodes with fda
50 episodes with fda
47 episodes with fda
51 episodes with fda
61 episodes with fda
97 episodes with fda
78 episodes with fda
41 episodes with fda
38 episodes with fda
59 episodes with fda
64 episodes with fda
56 episodes with fda
55 episodes with fda
97 episodes with fda
73 episodes with fda
59 episodes with fda
49 episodes with fda
99 episodes with fda
Israelis celebrate reports of a ceasefire; on Culture Friday, John Stonestreet covers the FDA approval of generic mifepristone and Bari Weiss at CBS; and Collin Garbarino reviews Tron: Ares. Plus, the Friday morning newsSupport The World and Everything in It today at wng.org/donateAdditional support comes from Cedarville University—a Christ-centered, academically rigorous university located in southwest Ohio, equipping students for Gospel impact across every career and calling. Cedarville integrates a biblical worldview into every course in the more than 175 undergraduate and graduate programs students choose from. New online undergraduate degrees through Cedarville Online offer flexible and affordable education grounded in a strong Christian community that fosters both faith and learning. Learn more at cedarville.edu, and explore online programs at cedarville.edu/onlineFrom Covenant College, where Christian faculty equip students for their callings through hard ideas, deep questions, and meaningful work. covenant.edu/worldAnd from Ambassadors Impact Network, helping entrepreneurs who are looking for more than just funding. Discover a community of Christian faith-led investors. More at ambassadorsimpact.com
In this week's episode, we wade into the bloody (and sometimes gory) side of science. Part 1: Shawn Musgrave wants to donate blood, but runs headfirst into the FDA's lifetime ban on gay men as donors. Part 2: While working with the condor recovery program, Molly Astell opens a freezer to find every researcher's nightmare. Shawn Musgrave is a lawyer, journalist, lawyer-who-represents-journalists, and somewhat recent transplant to New York. His work has appeared in The Intercept, POLITICO, The Verge, VICE, and the Boston Globe, among other publications, as well as in the Netflix docuseries How to Fix a Drug Scandal. Molly Astell is a wildlife biologist who originally never wanted to be one of those "bird people", yet went on to exclusively work with endangered birds in their career. Fourteen of those years were spent working as part of the California condor recovery program in a variety of different roles, mostly with the wild condors in southern California, but also with the captive breeding birds in Boise, ID. Currently, they are a graduate student at Boise State University doing research with condor data they helped to collect, and is discovering the joys of teaching biology to undergraduates.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
AlabamaSen.Britt calls on Dems to Work and hold conversation at the same timeSen. Tuberville says Sharia Law has no place in the US at any levelTwo AL congressman criticize the FDA's generic abortion drug approvalFather of injured student in Tuscumbia not stopping his pursuit for answersA federal judge rules against the ATFE and in favor of firearm dealersHaley Harris is in AL jail after extradition to face kidnapping chargesDNA testing for local fish only to happen at Gulf Shores Shrimp FestivalNational200 US troops head to the Middle East to help in peace deal and transitionVA grand jury issues indictment of mortgage fraud for NY AG Letitia JamesFederal judge issues injunction against National Guard in city of ChicagoDominion Voting Systems has been acquired by a Republican!Harper Collins apologizes for book claiming Jeffery Epstein introduced Melania to Donald Trump
The integrity of evidence-based policy is under threat when political agendas override scientific rigor. In this episode, Dr. Robert Califf, former FDA Commissioner and cardiologist, reflects on his experience leading the FDA and the agency's critical role in protecting public health through rigorous, science-based regulation across multiple sectors. He warns that political interference, disinformation, and mistrust threaten health outcomes but believes meaningful collaboration can still restore integrity and progress. Tune in and learn how protecting science-based regulation may be one of the most important public health actions of our time! Learn more about your ad choices. Visit megaphone.fm/adchoices
Megyn Kelly is joined by Buck Sexton, co-host of "The Clay and Buck Show," to talk about Trump's massive Middle East deal between Israel and Hamas, Trump's legacy and skills as a dealmaker, how even the left and media are being forced to give him credit now, what happens next in the Middle East, the truth about Hamas and the false equivalency some make with Israel, and more. Then Dr. Patrick Soon-Shiong, CEO of Los Angeles Times Media Group, joins to talk about why he stopped his paper from publishing their Kamala Harris endorsement, his reaction to the fallout, his decision to take the LA Times public and give power to the audience, Bari Weiss taking over as head of CBS News, the future of the media, his work in trying to find a cure for cancer, his challenge trying to get the FDA to approve this new procedure, the effectiveness of his method, why he thinks President Trump could be the person to implement this massive scientific breakthrough, and more. Soon-Shiong- https://x.com/drpatsoonshiongSexton- https://www.youtube.com/@BuckSexton Unplugged: Switching is simple, Visit https://Unplugged.comand order your UP phone today!Masa Chips: Get 25% off your first order | Use code MK at https://MASAChips.com/MKVandy Crisps: Get 25% off your first order | Use code MK at https://vandycrisps.com/MKGeviti: Go to https://gogeviti.com/megynand get 20% off with code MEGYN. Follow The Megyn Kelly Show on all social platforms:YouTube: https://www.youtube.com/MegynKellyTwitter: http://Twitter.com/MegynKellyShowInstagram: http://Instagram.com/MegynKellyShowFacebook: http://Facebook.com/MegynKellyShow Find out more information at:https://www.devilmaycaremedia.com/megynkellyshow Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Patrick Bet-David sits down with investigative journalist Gerald Posner to expose how the government protected Big Pharma during the OxyContin crisis, the FDA's cover-ups, and the Vatican's hidden financial dealings.———Ⓜ️ CONNECT ON MINNECT WITH GERALD POSNER: http://bit.ly/3WsdS8PⓂ️ PBD PODCAST CIRCLES: https://bit.ly/4mAWQAP
The government shutdown continues with no obvious end in sight, and while it theoretically should not affect entitlement programs like Medicare and Medicaid, the lapse of some related authorizations — like for Medicare telehealth programs — is leaving some doctors and patients high and dry. Meanwhile, the FDA quietly approved a new generic abortion pill, prompting a not-so-quiet reaction from anti-abortion groups. Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Sarah Karlin-Smith of Pink Sheet join KFF Health News' Julie Rovner to discuss those stories and more. Also this week, Rovner interviews Sarah Grusin of the National Health Law Program about the GOP's misleading claims that Democrats shut down the government in pursuit of free health care for immigrants who are in the country illegally. Plus, for “extra credit” the panelists suggest health policy stories they read this week that they think you should read, too: Julie Rovner: The Washington Post's “How Some Veterans Exploit $193 Billion VA Program, Due to Lax Controls,” by Craig Whitlock, Lisa Rein, and Caitlin Gilbert. Tami Luhby: The Washington Post's “Trump Plan Would Limit Disability Benefits for Older Americans,” by Meryl Kornfield and Lisa Rein. Sarah Karlin-Smith: The New York Times' “It's Just a Virus, the E.R. Told Him. Days Later, He Was Dead,” by Lisa Miller. Alice Miranda Ollstein: The 19th's “Ice Fears Put Pregnant Immigrants and Their Babies at Risk” by Mel Leonor Barclay and Shefali Luthra. Hosted on Acast. See acast.com/privacy for more information.
Maintenance therapy with ICIs (atezolizumab or durvalumab) is already established in extensive stage small-cell lung cancer, but lurbinectedin enters the chat with a recent FDA approval. Next up - tarlatamab? IMforte (maintenance lurbinectedin + atezolizumab): https://doi.org/10.1016/S0140-6736(25)01011-6 DeLLphi-303 (phase 1b maintenance tarlatamab + ICI): https://doi.org/10.1016/S1470-2045(25)00480-2
It's Thursday, October 9th, A.D. 2025. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com. I'm Adam McManus. (Adam@TheWorldview.com) By Jonathan Clark Pakistani pastor dies after 13-year jail sentence A pastor in Pakistan died on Sunday after languishing in prison for 13 years. Pastor Zafar Bhatti founded Jesus World Mission Church ministry. Back in 2012, he was falsely accused of insulting Islam. Authorities finally overturned his conviction this month, releasing him last Wednesday. The 62-year-old pastor died days after from cardiac arrest at his home. The British Asian Christian Association helped defend the pastor in court. The organization stated, “Though his earthly journey has ended, Zafar's faith, endurance, and ultimate vindication remain a powerful testament to hope in Christ amidst persecution.” Nigerian Anglican Church appalled that woman chosen to be new church head The Anglican Church of Nigeria declared spiritual independence from the Church of England on Tuesday. The announcement came in response to the Church of England's appointment of Sarah Mullally as the Archbishop of Canterbury. She is the first woman to hold the position. She also supports abortion and faux homosexual marriage. Archbishop Henry Ndukuba is the Primate of the Church of Nigeria. He stated, “[Mullally's] appointment marks a tragic departure from biblical orthodoxy. . . . We remain Anglicans — but not under Canterbury. Our loyalty is to Christ and the truth of His Word, not to institutions that have abandoned it.” Police arrest man intent on blowing up church with Supreme Court Justices In the United States, police arrested a man on Sunday who had hundreds of explosive devises outside of St. Matthews Cathedral in Washington, D.C. Police made the arrest before an annual service traditionally attended by U.S. Supreme Court justices. According to court records, the man's notebook expressed animosity toward Supreme Court justices, the Catholic Church, Jews, and immigration enforcement officials. FBI cuts ties with God-hating Southern Poverty Law Center The Federal Bureau of Investigation announced last week it has cut ties with the Southern Poverty Law Center. The far-left nonprofit is known for listing conservative and Christian organizations as “hate groups,” primarily because they affirm God's design for sexuality and marriage. FBI Director Kash Patel posted on X, “The Southern Poverty Law Center long ago abandoned civil rights work and turned into a partisan smear machine. Their so-called ‘hate map' has been used to defame mainstream Americans and even inspired violence. That disgraceful record makes them unfit for any FBI partnership.” Florida, Louisiana, Missouri & Texas sue FDA over mail-order Abortion Kill Pill The state of Louisiana joined a lawsuit against the Food and Drug Administration on Monday. Florida, Missouri, and Texas are also on the case. They are challenging the FDA's 2023 policy that allows mail-order abortion drugs. Louisiana's filing states, “Every year, doctors and activists in states like California and New York mail a U.S. Food and Drug Administration (FDA)-approved abortion drug called mifepristone to thousands of Louisiana residents for the express purpose of causing abortions in Louisiana that are blatantly unlawful.” Gold hit $4,000 per ounce first time ever On Tuesday, spot gold prices hit $4,000 per ounce for the first time in history. That's up 50% from January. Silver is up 60% this year. The demand for gold is up as investors hedge against economic uncertainty. Financial analyst Rhona O'Connell told Reuters, “Background factors are much the same as before, in terms of geopolitical uncertainty, with the added spice of the (U.S.) government shutdown.” Prison Fellowship and Bible League to send 620,000 Bibles to prisoners And finally, Prison Fellowship International and Bible League International are partnering to distribute over half a million Bibles. The 620,000 Bibles will go to prisoners in 20 countries over the next five years. Frank Lofaro with Prison Fellowship International said, “God's Word has the power to reach prisoners in their darkest moments with the light of Jesus Christ. Through this partnership, prisoners who come to know Jesus through our evidence-based, in-prison programs are equipped to grow in their faith through a Bible that they can understand and that speaks to their circumstances.” Luke 4:18 says, “The Spirit of the LORD is upon Me, because He has anointed Me to preach the gospel to the poor; He has sent Me to heal the brokenhearted, to proclaim liberty to the captives and recovery of sight to the blind, to set at liberty those who are oppressed.” Close And that's The Worldview on this Thursday, October 9th, in the year of our Lord 2025. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.
This podcast is sponsored by YARAL Pharma. In this episode, we are focusing on the management of hypothyroidism -- a treatable, but not curable condition – and will explore unique challenges for patients with hypothyroidism in long-term care – from tolerability and formulation considerations to consistent dosing and patient needs. Dr. Tamara Ruggles is not affiliated with YARAL Pharma. All views and opinions regarding hypothyroidism are solely her own and are not attributable to YARAL or the Pharmacy Podcast Network. IMPORTANT SAFETY INFORMATION for levothyroxine sodium capsules INDICATION AND USAGE Levothyroxine sodium capsules are L-thyroxine (T4) indicated for adults and pediatric patients 6 years and older with: Hypothyroidism - As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression - As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well differentiated thyroid cancer Limitations of Use: Levothyroxine sodium capsules are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with Levothyroxine sodium capsules may induce hyperthyroidism. Levothyroxine sodium capsules are not indicated for treatment of transient hypothyroidism during the recovery phase of subacute thyroiditis WARNING: NOT FOR THE TREATMENT OF OBESITY OR FOR WEIGHT LOSS Thyroid hormones, including levothyroxine sodium capsules, either alone or with other therapeutic agents, should not be used for the treatment of obesity or for weight loss. In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects. Contraindications Uncorrected adrenal insufficiency Warnings and Precautions Cardiac adverse reactions in the elderly and in patients with underlying cardiovascular disease: Initiate Levothyroxine sodium capsules at less than the full replacement dose because of the increased risk of cardiac adverse reactions, including atrial fibrillation Myxedema coma: Do not use oral thyroid hormone drug products to treat myxedema coma Acute adrenal crisis in patients with concomitant adrenal insufficiency: Treat with replacement glucocorticoids prior to initiation of levothyroxine sodium capsules treatment Prevention of hyperthyroidism or incomplete treatment of hypothyroidism: Proper dose titration and careful monitoring is critical to prevent the persistence of hypothyroidism or the development of hyperthyroidism Worsening of diabetic control: Therapy in patients with diabetes mellitus may worsen glycemic control and result in increased antidiabetic agent or insulin requirements. Carefully monitor glycemic control after starting, changing, or discontinuing thyroid hormone therapy Decreased bone mineral density associated with thyroid hormone over-replacement: Over-replacement can increase bone reabsorption and decrease bone mineral density. Give the lowest effective dose Adverse Reactions Common adverse reactions with levothyroxine therapy are primarily those of hyperthyroidism due to therapeutic overdosage. They include the following: General: fatigue, increased appetite, weight loss, heat intolerance, fever, excessive sweating Central Nervous System: headache, hyperactivity, nervousness, anxiety, irritability, emotional ability, insomnia Musculoskeletal: tremors, muscle weakness Cardiovascular: palpitations, tachycardia, arrythmias, increased pulse and blood pressure, heart failure, angina, myocardial infarction, cardiac arrest Respiratory: dyspnea Gastrointestinal (GI): diarrhea, vomiting, abdominal cramps, elevations in liver function tests Dermatologic: hair loss, flushing Endocrine: decreased bone mineral density Reproductive: menstrual irregularities, impaired fertility Adverse Reactions in Children Pseudotumor cerebri and slipped capital femoral epiphysis have been reported in children receiving levothyroxine therapy. Overtreatment may result in craniosynostosis in infants and premature closure of the epiphyses in children with resultant compromised adult height. Seizures have been reported rarely with the institution of levothyroxine therapy. Hypersensitivity Reactions Hypersensitivity reactions to inactive ingredients (in this product or other levothyroxine products) have occurred in patients treated with thyroid hormone products. These include urticaria, pruritis, skin rash, flushing, angioedema, various GI symptoms (abdominal pain, nausea, vomiting and diarrhea), fever, arthralgia, serum sickness and wheezing. Hypersensitivity to levothyroxine itself is not known to occur. Drug Interactions: Many drugs and some foods can exert effects on thyroid hormone pharmacokinetics (e.g., absorption, synthesis, secretion, catabolism, protein binding, and target tissue response) and may alter the therapeutic response to Levothyroxine sodium capsules. Administer at least 4 hours before or after drugs that are known to interfere with absorption. See full prescribing information for drugs that affect thyroid hormone pharmacokinetics and metabolism. To report SUSPECTED ADVERSE REACTIONS, contact Yaral Pharma Inc. at 1-866-218-9009, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. For Full Prescribing Information, including Boxed Warning, go to www.yaralpharma.com/levothyroxine-pi.
“We don't view a person with chronic pain as someone who has a chronic illness and the effect of that is we can't follow patients continuously over prolonged periods of time,” says Dr. Jacob Hascalovici, a neurologist and pain specialist based in New York City. In co-founding Bliss Health, Dr. Jacob, as he is known, has set out to create a continuous care model for chronic pain treatment that matches the approach taken for patients with diabetes or high blood pressure. The Bliss Health formula includes an initial meeting with a physician that produces a care plan; remote therapeutic monitoring on an ongoing basis; and a monthly meeting with a nurse to review data and determine next steps, including additional appointments with physicians as needed. All of this occurs via a digital platform which provides a welcome option for patients with mobility issues and can fill gaps in access to specialists, especially in rural areas. Dr. Jacob is also hoping to make chronic pain patents feel respected, which is not always the case in their encounters with the healthcare system. “Because pain is not something that can be seen or measured, oftentimes patients feel marginalized, dismissed and disempowered by providers.” Join Raise the Line host Lindsey Smith for a valuable conversation that also touches on policy changes that could strengthen telemedicine, and has details on the first non-opioid based pain medication to receive FDA approval in over 20 years.Mentioned in this episode:Bliss Health If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
On this episode of Vitality Radio, Jared dives deep into one of the most overlooked yet essential nutrients: vitamin B1, also known as thiamine. While other B vitamins often take the spotlight, B1 is critical for energy production, nerve function, and overall resilience. Jared explains why not all forms of B1 are created equal, highlighting the difference between standard water-soluble versions and the more bioavailable fat-soluble forms such as benfotiamine and sulbutiamine. You'll learn how benfotiamine supports nerve health and circulation, while sulbutiamine penetrates the brain to deliver steady energy and focus without the jitters or crash of stimulants. Drawing from history, research, and his own formulating experience, Jared shares how these powerful forms of B1 help protect against sugar damage, reduce oxidative stress, and enhance everyday vitality. Whether you struggle with fatigue, nerve challenges, or simply want more consistent energy, understanding the right form of vitamin B1 could be a game-changer.Products:Ultimate Vitality MultiNerve ReverseActive B ComplexBenfotiamine Aloe Life Detox Plus + CellCore Binder (Vitality Radio POW! Product of the Week Buy any CellCore Binder and Get Aloe Life Detox Plus Formula FREE with PROMO CODE: POW12)#543: How to Choose the Right Binder for Detox, Parasites, Mold, and MetalsAdditional Information:#417: The B Vitamins: Understanding Their Roles and What They Can Do For YouVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
On July 21st 2025, the FDA convened a hearing on maternal use of antidepressants during pregnancy and the impact this use has on fetal development. Around 400,000 children in the United States are born each year whose mothers took antidepressants while pregnant, and so it's easy to see the societal importance of this topic. What are the risks to the fetus, the newborn, and the long-term development of that child? Adam Urato and Joanna Moncrieff were members of that FDA panel, and so too were several others well-known to MIA readers, including David Healy and Joseph Witt-Doerring. The purpose of the panel was to assess whether the FDA needed to put a warning on antidepressants related to their use in pregnancy, and most on the panel spoke of research that told of the need to do so. However, after the panel concluded, the American Psychiatric Association and other medical associations, most notably the American College of Obstetricians and Gynecologists, responded with what can only be described as howls of outrage, issuing press releases and telling the public that the panel was biased and that the real risk during pregnancy was untreated mental illness. These medical organizations asserted that the increased risk of adverse outcomes for children born to depressed mothers is due to the illness and not the drug, and that there was plenty of evidence that antidepressants were a helpful and even life-saving treatment for maternal depression. Here is where we are today. That FDA hearing put two narratives on public display, and most media reports embraced the narrative put forth by the medical organizations. What we will do today is review the evidence that exists on this topic and the response by the medical guilds to a public airing of that evidence. Dr. Adam Urato is Chief of Maternal and Fetal Medicine at the Metro West Medical Center in Framingham, Massachusetts, and he has been speaking and writing about the risk of medications used during pregnancy for years. Dr. Joanna Moncrieff is a UK psychiatrist and researcher who was a co-founder of the Critical Psychiatry Network and is well known for her research on the safety and efficacy of psychiatric drugs. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2025. Produced by James Moore https://www.jmaudio.org
How can AI really help advance medicine? Should patients and care teams be seeking second opinions from LLMs? This week, Reid and Aria sit down with physician-scientist Dr. David Fajgenbaum, who repurposes existing drugs to save lives—including his own. David shares his journey from receiving last rites as a young medical student to co-founding Every Cure, a nonprofit using AI to come up with ways existing drugs can be repurposed to treat every disease and every patient possible. On this special episode, filmed live in New York City, David, Reid, and Aria explore the circuit of hope, action, and impact that drives medical discovery; the technical and ethical challenges around accelerating AI in healthcare; “agent optimization” as the new “search engine optimization;” and what a future of faster diagnoses and treatment could look like. The result is a conversation about resilience, innovation, and unlocking cures that are already within our reach. For more info on the podcast and transcripts of all the episodes, visit https://www.possible.fm/podcast/ Topics: 3:00 - Hellos and intros 3:29 - A promise to his mother and the origin of AMF 6:23 - From grief support to medical school 9:18 - Near-death experiences and founding a research network 14:38 - What kept David going at death's door 16:19 - Discovering a potential treatment and testing it on himself 19:42 - Why drug repurposing is a faster, cheaper complement to drug discovery 22:14 - Co-founding Every Cure and scaling discovery with AI 25:20 - Demo: Building MATRIX and how the algorithm makes predictions 28:41 - Breast cancer and Lidocaine as a case study 30:07 - Why human review is essential in AI for medicine 34:08 - Car exhaust fumes example and FDA pathways 37:31 - Reid's surprise million-dollar donation for Every Cure compute 39:24 - What AI can unlock across healthcare 41:46 - Building an impact team to close the repurposing loop 47:32 - Improving systemic incentives for generics 54:58 - FDA approval pathways and label change challenges 57:21 - Three life-saving repurposing stories 1:02:20 - Rapid-fire questions Select mentions: Hidden Potential by Adam Grant Chasing My Cure by Dr. David Fajgenbaum Every Cure David's TED Talk: https://youtu.be/sb34MfJjurc?si=GcVleWHZuJ9MqLgS Manas AI Possible is an award-winning podcast that sketches out the brightest version of the future—and what it will take to get there. Most of all, it asks: what if, in the future, everything breaks humanity's way? Tune in for grounded and speculative takes on how technology—and, in particular, AI—is inspiring change and transforming the future. Hosted by Reid Hoffman and Aria Finger, each episode features an interview with an ambitious builder or deep thinker on a topic, from art to geopolitics and from healthcare to education. These conversations also showcase another kind of guest: AI. Each episode seeks to enhance and advance our discussion about what humanity could possibly get right if we leverage technology—and our collective effort—effectively.
Jackie is joined by the incredible Michelle Collins to discuss, fixing and being fixed in relationships, bringing back bullying and shame, and why the housewives need a villain.Thanks for supporting my sponsors:Honeylove: For a limited time, get 20% off your entire order at www.honeylove.com/bibleHome Chef: For a limited time, get 50% off and free shipping for your first box. Plus free dessert for life at www.HomeChef.com/BIBLEPique: With the Deep Hydration Protocol, get 20% off for life when you subscribe. Plus a complimentary gift to elevate your routine at www.PiqueLife.com/BIBLEBetterHelp: Get 10% off your first month at www.BetterHelp.com/BITCHBIBLEAddyi: Check out the FDA-approved treatment for certain premenopausal women who are bothered by low libido and want their sex drive back at www.Addyi.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Kara's in The Secret Room to answer the question: What happens when your mom moves her secret lover into the basement? HERS Visit forhers.com/SECRET for your personalized weight loss treatment options. Hers Weight Loss by Hers is not available everywhere. Compounded products are not approved or reviewed for safety, effectiveness, or quality by the FDA. Prescription required. See website for full details, important safety information, and restrictions. Actual price depends on product and plan purchased. HOME CHEF For a limited time, get 50% off and free shipping for your first box PLUS free dessert for life! HomeChef.com/SECRET. Must be an active subscriber to receive free dessert. MINT MOBILE Make the switch! MINTMOBILE.com/SECRET. PICTURES Kara shared pictures of herself, her mom, her sister and boyfriend! They are waiting for you on Threads, Facebook, Instagram and X. Handle: @secretroompod. YOUTUBE The Secret Room is now on YouTube! THE SECRET ROOM | UNLOCKED Ella is back for the conclusion of her secret: her parents didn't tell her she had a deadly disease. After the devastating passing of her little brother from the same condition, Ella began to experience intense pain herself. She tells us about her bold journey that spanned two continents seeking the answers she couldn't get at home. Host: Susie Lark. The Secret Room | Unlocked is yours when you support your favorite indie podcast that could with a membership at patreon.com/secretroom, Apple Podcasts or Spotify. There's a free trial! ALL OUR SPONSORS See all our sponsors past and present, and their offers, many of which are still valid: secretroompodcast.com/codes FACEBOOK DISCUSSION GROUPThere's even more fun at The Secret Room Podcast Facebook Discussion Page! Just ask to join, all are welcome. :) YOUR SECRET Click "Share a Secret" at secretroompod.com! PODCAST TEAM Producer: Susie Lark. Story Development: Luna Patel. Music and Theme: Breakmaster Cylinder. LISTENER SURVEY Take our Listener Survey at SecretRoomPod.com!
In this candid, practice-focused conversation, Joe is joined by Norwegian psychologist and researcher Ivar Goksøyr to explore how therapists' own healing journeys can measurably improve client outcomes—and why MDMA-assisted experiences, used thoughtfully, may be a uniquely powerful catalyst for professional development. Ivar shares lessons from Norway's psychedelic research team (PTSD and the world's first MDMA-for-depression trial), his clinic Psykologvirke in Oslo, and his online course, “The Wounded Healer,” which uses authentic footage from his FDA-approved MAPS volunteer MDMA sessions to illuminate real clinical processes, countertransference, and the “inner healing intelligence” as a working metaphor rather than dogma. The discussion ranges from implementation realities (laws, ethics, and conservative regulatory cultures) to the pragmatic: how an MDMA experience helped Ivar resolve chronic anxiety reactions in the therapy chair, reduced burn-out, increased receptivity, and improved attunement—changes he believes many clinicians can cultivate when personal growth is prioritized alongside methods training. He outlines a developing collaboration with the University of Oslo on Empathogen-Assisted Therapies Development—not to “dose for certification,” but to support therapists' self-awareness and resilience in legally sanctioned research contexts. They also compare compounds: why MDMA may be easier to integrate into mainstream psychiatry than classic tryptamines (fewer projective processes, more biographical focus, smoother affect regulation), while acknowledging the immense promise—and higher demands—of psilocybin and other psychedelics. Throughout, they emphasize humility, guardrails, and the need to keep learning as the field scales (with frank reflections on ketamine's mixed rollout and avoiding idealization/devaluation cycles). Highlights Why therapist factors often outweigh modality—and how personal work translates into better outcomes. Using real session video (with Ivar as participant) to normalize vulnerability, illuminate process, and train pattern recognition. Regulatory and ethical nuances of self-experience in training; building consensus before policy change. Inner healing intelligence as a clinical metaphor aligned with Rogers, Rank, and psychodynamic concepts (unconscious therapeutic alliance). MDMA vs. classic psychedelics for implementation; sequencing with ketamine in public systems. Global classroom: 270+ clinicians from every continent; course structure centered on reflection, discussion, and live analysis.
Connie Zack, co-founder of Sunlighten Sauna, joins Dr. Kahn to discuss the science and benefits behind infrared sauna and red light therapy. Sunlighten is the leading brand in “full spectrum” infrared saunas, designed to deliver maximum results even at lower temperatures. Connie explains how infrared sauna therapy can improve cardiovascular health and support healthy blood pressure—benefits that are well documented in clinical studies. She also explores the growing field of red light therapy (photobiomodulation), which offers additional wellness advantages and even includes FDA-approved applications. This episode dives into how combining these two therapies can optimize overall health and recovery. You'll enjoy this insightful and practical conversation.
Presented by Happy Dad Hard Seltzer. Find Happy Dad near you http://happydad.com/find (21+ only). Video is available on https://youtube.com/@onenightwithsteiny/videos. Follow Steiny on Instagram http://instagram.com/steiny. Get harder, longer-lasting erections with Ro Sparks: $15 off first order of medication to get hard at http://ro.co/steiny Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review by the FDA. For full safety information, go to http://ro.co/safety Part of the Shots Podcast Network (shots.com). You can listen to the audio version of this podcast on Spotify, Apple Podcasts & anywhere you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices
Our latest episode of The Walk Humbly Podcast, Bishop Burbidge: Comments on Pope Leo's XIV anticipated first apostolic exhortation, Delexi te (“I have loved you”) on caring for the poor and encourages us to read the document in full Expands upon his column in the Arlington Catholic Herald what the Catholic Church teaches on migration: “We don't tire of doing the work of welcoming the stranger in our midst…. [for] in doing so we welcome Christ” Shares why news of the recent FDA approval of a new generic version of the chemical abortion drug, mifepristone, is deeply troubling and thus a call to prayer and action Recaps some of the central messages of his homily from the recent Mass for Domestic Violence Awareness Month at the Basilica of the National Shrine of the Immaculate Conception Offers perspective on awards and honors for Catholic politicians; read his statement Celebrates the 230th anniversary of the Basilica of Saint Mary in Alexandria, inviting all parishioners to gratitude and renewal; see the coverage Explains why the message of Pope Francis' encyclical Fratelli tutti — published five years ago — remains relevant today; read his statement Encourages the faithful to renew their commitment to pray the Rosary daily this month for peace, echoing the invitation of the Holy Father; learn more
It's Tuesday, October 7, A.D. 2025. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com. I'm Adam McManus. (Adam@TheWorldview.com) By Kevin Swanson Nigerian military opened fire on Christians Christian persecution at the hands of Muslim terrorists in Nigeria was tough enough. Now, Truth Nigeria reports that the Nigerian military has opened fire on Christians in the Benue State — this time killing three young men. Ten others sustained life-threatening gunshot wounds and are receiving medical treatment in Jato-Aka. The local chief said, “We no longer need the military in our land. … They have joined Fulani to kill us and take over our land. They have turned their guns against us. … The betrayal is unbearable. Enough is enough. President Tinubu and Governor Alia should hear this message and take immediate action.” Newsweek urges State Dept to declare Nigeria “Country of Particular Concern” Newsweek.com has joined the voices of comedian Bill Maher and others, pointing to the egregious level of Christian killings in Nigeria. The Nigerian government has “categorically” denied that terrorists are waging a systematic genocide against Christians in the country. Newsweek noted that the Trump State Department has thus far failed at making Nigeria a “Country of Particular Concern.” Europe's swirling politics France just lost its third prime minister in about a year. Sébastien Lecornu was the latest, and he just resigned yesterday after only 27 days in office. This marks the most instability for the French government in 70 years. France's nationalist, anti-immigration party increased from obtaining 4% of parliamentarian seats in 2008 to 37% in 2024. Germany lost its government earlier this year. Germany's anti-immigration party is supported by 24% of the country, up from virtually nothing ten years ago. And Portugal faces instability, still run by a minority government, having completed its third election in three years in May. Portugal's nationalist party increased from half percent in 2019 to 23% in the 2025 elections. Also, the Netherlands, Sweden, Finland, and Italy have experienced wide swings in governance — shifting to a nationalist position over the last 5-10 years. Daniel 2:21 reminds us that it is God who “changes times and seasons; He removes kings and sets up kings; He gives wisdom to the wise and knowledge to those who have understanding.” Cuba sends 5,000 troops to aid Ukraine despite grinding poverty Reuters reports that Cuba is supporting the Ukrainian War now with up to 5,000 troops. The communist country's economy is lagging badly — suffering a four-year decline in its Gross Domestic Product, with another decline forecasted for this year, reports InDepthNews.com. Inflation is running at 28%. The nation has suffered at least five energy blackouts this year so far. And 89% of the populace suffers from “extreme poverty” according to a recent survey. Seven out of ten Cubans have stopped eating breakfast, lunch, or dinner due to lack of money or food shortages. Only 15% have been able to eat three meals a day without interruption. That compares with the next poorest countries in Central America. Just 16% of Guatemalans and 27% of folks in Honduras have to deal with these levels of extreme poverty. Supremes consider Trump's tariffs, Hawaii's gun restrictions, & trans sports As the US Supreme Court reconvenes, the docket holds a slew of cases. They include the legitimacy of the Trump Tariffs, the president's removal of high level administrative bureaucrats, Colorado's ban on counselors helping minors out of homosexual sin, Hawaii's gun restrictions, and bans issued by red states on boys pretending to be girls playing in girls' sports in public schools. Trump's FDA approve a new Abortion Kill Pill The Trump Administration's Food and Drug Administration approved another abortion kill pill to accommodate the killing of children in their mother's wombs. Last week, the FDA approved Evita Solutions' generic abortion drug for the US market. This is hardly in line with the administration's pledge to “review all the evidence—including real-world outcomes—on the safety of the drug” issued just last month. Ostensibly, the big concern is the health of the mother. The FDA reports 36 deaths attributed to the abortion kill pill thus far, but 7.5 million murdered babies. 63% of the annual abortions committed in the country today are attributed to the abortion kill pill. Isaiah 29:15-16 speaks to this. The prophet wrote, “Woe to you who hide deep from the Lord your counsel, whose deeds are in the dark, and who say, “Who sees us? Who knows us?” You turn things upside down! Shall the potter be regarded as the clay, that the thing made should say of its maker, “He did not make me”; or the thing formed say of him who formed it, “He has no understanding”? Mt. Everest hiker died, 200 others stranded in shock blizzard And finally, one hiker has died and 200 others are still stranded in a shock blizzard on Mount Everest over the weekend. The blizzard took about 1,000 hikers by surprise. Thus far this year, five people have died on Everest. Last year's total was eight, and 18 others died on the treacherous slopes in 2023. About 800 people attempt to summit the tallest mountain in the world each year. Close And that's The Worldview on this Tuesday, October 7th, in the year of our Lord 2025. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.
The beginning of the new Supreme Court term has officially begun, and a storm of possible bad outcomes is brewing. Jessica Mason Pieklo, Co-Chief Content Officer of Rewire News Group and co-host of Boom! Lawyered, sits down with us to give us a holistic view of cases, tells us what to expect in the new court term, and highlights which cases we should be keeping an eye on in the lower courts.A collection of cases over the summer gave us a peek into the health of the Supreme Court—especially the conservative majority's willingness to facilitate the Trump administration's agenda. Coming up this term includes a challenge to Colorado's ban on conversion therapy (Chiles v. Salazar), a West Virginia ban on transgender girl's participation in sports (B.P.J. v. West Virgina Board of Education), a case on no-knock searches by law enforcement, and a redistricting case in Louisiana (Louisiana v. Callais). Cases in the lower courts that are not yet on the Supreme Court docket (but could head there soon) include challenges to state shield laws and administration attacks to mifepristone and the FDA.For more information, check out Pantsuit Politics: https://www.pantsuitpoliticsshow.com/s/podcastSupport the showFollow Us on Social: Twitter: @rePROsFightBack Instagram: @reprosfbFacebook: rePROs Fight Back Bluesky: @reprosfightback.bsky.social Buy rePROs Merch: Bonfire store Email us: jennie@reprosfightback.comRate and Review on Apple PodcastThanks for listening & keep fighting back!
What happens to America’s health when Washington grinds to a halt? In this episode of The Health Advocates, we break down the latest federal government shutdown and what it means for public health agencies across the country. We explain what a shutdown actually is, drawing from past shutdowns over the last 30 years, and then dive into the immediate and long-term impacts on the CDC, FDA, NIH, and other agencies that millions of people depend on for research, vaccines, food safety, and emergency response. We also look at the political stalemate behind the shutdown, focusing on Democrats’ push to restore pending cuts to Affordable Care Act subsidies and what those cuts could mean for healthcare costs. Finally, we explore whether there’s a realistic path to resolution soon—and what’s at stake for patients and the healthcare system if Congress fails to act. Contact Our Host Steven Newmark, Chief of Policy at GHLF: snewmark@ghlf.org A podcast episode produced by Ben Blanc, Director, Digital Production and Engagement at GHLF. We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org Listen to all episodes of The Health Advocates on our website (https://ghlf.org/the-health-advocates) or on your favorite podcast channel.See omnystudio.com/listener for privacy information.
SUPPORT OUR WORK: OTPLinks.com
In recent months, public health advocates in the United States have raised concerns about proposed changes to vaccine policy, cuts to food assistance programs, rollbacks of environmental protections and reductions in public health staffing. Chief among them has been Dr. Georges Benjamin who, as executive director of the American Public Health Association (APHA) since 2002, has led national efforts to create a healthier America. Raise the Line host Lindsey Smith recently sat down with Dr. Benjamin to understand more about the current state of public health and explore the path forward, and learned that a top priority for APHA is battling the misinformation that Dr. Benjamin believes is fueling support for many of these changes. “The challenge we have right now is that as a society, we've gone into our little corners and live in our own ecosystems. More people are getting their information from a single source and they're not validating that information to make sure that it's true.” Tune into this thoughtful and timely conversation to hear Dr. Benjamin's advice for curbing the spread of misinformation, how APHA is trying to help people understand the value of public health initiatives, and what the U.S. can learn from other countries about improving public health. Mentioned in this episode:American Public Health Association If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
Brigham Buhler is a healthcare entrepreneur transforming America's broken system. As founder of Ways2Well, owner of Revive Rx Pharmacy, and an investor in psychedelic research, he champions a model of care that prioritizes patients over profits through preventative medicine, transparency, and innovation. His work is guided by a few core convictions: -Former insider's perspective: With deep experience navigating the corrupt systems of pharmacy benefit managers (PBMs), insurance companies, and the FDA, Brigham knows firsthand how the system is stacked against patients. -Uncompromising advocate: He pushes to expose and dismantle the corporate capture of American healthcare. -Bold truth-teller: He believes in revealing the realities of the insurance Ponzi scheme and providing practical ways to bypass outdated systems. -Relentless reformer: He is dedicated to replacing a model that profits off sickness with one centered on health, longevity, and patient empowerment. Today's Sponsors: Black Rifle Coffee: https://www.blackriflecoffee.com LMNT: https://www.drinklmnt.com/clearedhot
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this special episode of The Drive, Peter addresses the recent headlines linking acetaminophen (Tylenol) use during pregnancy to autism in exposed children. Recognizing the confusion these claims have sparked among patients, listeners, and the broader public, Peter uses this episode to provide a framework for thinking critically about complex conditions and the research related to them. He highlights the dramatic rise in autism diagnoses over recent decades, noting that multifactorial conditions rarely have a single cause, and emphasizes the importance of resisting oversimplified explanations. Peter also stresses that humans are not naturally wired for scientific thinking, making disciplined frameworks like the Bradford Hill criteria essential for evaluating causality in epidemiology. Ultimately, he uses this framework to explore the evidence surrounding acetaminophen use during pregnancy and its potential link to autism. We discuss: Laying the groundwork for this discussion, the rise in autism rates, and the value in using frameworks [1:00]; The FDA pregnancy drug categories, where Tylenol falls within that framework, and a structured method for evaluating scientific evidence and causality [6:00]; What exactly are the claims being made about acetaminophen and autism? [13:45]; The increase in autism rates and why so many things are being linked to autism: the multiple comparisons problem [15:00]; Evaluating the review paper that triggered the recent concern over acetaminophen and autism [21:45]; Breaking down the largest studies on prenatal Tylenol exposure and autism: is there a causal link? [35:00]; Why observational studies can't prove causality, the role of confounding variables, and the importance of frameworks like the Bradford Hill criteria [43:30]; Applying the Bradford Hill criteria: testing the case for Tylenol and autism [45:45]; Putting it all together to answer the question: Does acetaminophen use during pregnancy increase the risk of autism? [56:15]; If autism risk is overwhelmingly genetic, what explains the dramatic rise in autism diagnoses? [59:15]; Other risk factors for autism: parental age, maternal health, environment, and where Tylenol fits in [1:09:15]; Medication use during pregnancy: balancing risks, benefits, and FDA categories [1:15:15]; Considerations for taking Tylenol during pregnancy [1:19:30]; Final thoughts: critical thinking, balanced risk assessment, and the importance of context when evaluating medications like Tylenol during pregnancy [1:22:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube
Our conversation today is on the recent FDA panel about the safety of antidepressants during pregnancy—and all the ways the panel got it wrong. It's not just about wrong information, but it's about the harm that wrong information does to people in the perinatal period. Join us to learn more about why this information from the FDA is so dangerous to women. Dr. Catherine Birndorf is a reproductive psychiatrist and the CEO, founder, and medical director of The Motherhood Center of New York. Dr. Birndorf is a founding director of the Payne Whitney Women's Program at Weill Cornell Medical Center at New York-Presbyterian Hospital, where she is a clinical associate professor of psychiatry. A graduate of Smith College, Dr. Birndorf attended Brown University Medical School and did her psychiatry residency at New York-Presbyterian Hospital. For 10 years, Dr. Birndorf was a regular mental health columnist for Self Magazine and appeared on numerous television programs, including the Today Show, Good Morning America, MSNBC, and CNN. Her most recent book, What No One Tells You: A Guide to Your Emotions from Pregnancy to Motherhood, was published by Simon & Schuster in 2019. Show Highlights: Dr. Birndorf's perspective on the FDA panel and their decisions: “I knew this was a disaster in the making.” The FDA panel was made up of 10 “experts” (8 men/2 women) who were biased and stacked against medication and mental illness. Women have been suffering, and they continue to suffer. The work of The Motherhood Center in supporting women who need help through mental illness The potential for harm is HUGE. What Dr. Birndorf wants people to know about mental illness and life-saving medications Dr. Birndorf's motivation to start The Motherhood Center Highlights of the support provided for women through The Motherhood Center The ways we “mother” have impacts on the generations to come; no mother should suffer with mental illness when transformation is possible. The Motherhood Center focuses on all the therapies and interventions that bring wellness, not just medications. Resources: Connect with Dr. Catherine Birndorf: Website, Instagram, Facebook, and What No One Tells You: A Guide to Your Emotions from Pregnancy to Motherhood Call the National Maternal Mental Health Hotline at 1-833-TLC-MAMA or visitcdph.ca.gov. Please find resources in English and Spanish at Postpartum Support International, or by phone/text at 1-800-944-4773. There are many free resources, like online support groups, peer mentors, a specialist provider directory, and perinatal mental health training for therapists, physicians, nurses, doulas, and anyone who wants to be more supportive in offering services. You can also follow PSI on social media, including Instagram, Facebook, and other platforms. Visit www.postpartum.net/professionals/certificate-trainings/for information on the grief course. Visit my website, www.wellmindperinatal.com, for more information, resources, and courses you can take today! If you are a California resident seeking a therapist in perinatal mental health, please email me about openings for private pay clients. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Happy Q4 Heart of Healthcare Listeners! We're back with your monthly Digital Health Download, where we discuss the biggest industry headlines of the month. We cover:
What happens when binge eating disorder and bipolar disorder collide? Research shows they co-occur in as many as one in four cases — and yet, many people living with both conditions feel completely alone. In this episode, host Gabe Howard shares his personal journey of living with bipolar disorder and binge eating disorder, including how food was his form of self-medication.Board certified psychiatrist Dr. Nicole Washington breaks down the clinical side: what binge eating disorder actually is, how it's diagnosed, and why treating it alongside bipolar disorder can get “tricky.” Listeners will learn: signs and symptoms of binge eating disorder (beyond overeating) why stability with bipolar disorder often makes binge eating easier to manage unique treatment challenges — including why the only FDA-approved medication for binge eating disorder may be destabilizing for people living with bipolar disorder Gabe and Dr. Nicole rip the lid off the shame, secrecy, and stigma surrounding binge eating disorder, especially when it coincides with bipolar disorder. With honesty and compassion, they share practical treatment insights, real hope, and a powerful reminder: You are not alone. Whether you're having trouble or supporting someone you love, this episode delivers validation, guidance, and the encouragement you need to take the next step toward healing and living your best life. "I weighed over 550 pounds and I knew that I was unhealthy. But I didn't really see binge eating disorder as a mental health problem because bipolar disorder sucked all the oxygen out of the room. And I was lucky, I did go from over 550 pounds down to the 200 that I weigh now, because I had the right interventions. I treated both bipolar disorder and binge eating disorder. But I imagine that many listeners, they don't realize the connection between these two." ~Gabe Howard, Host Our host, Gabe Howard, is an award-winning podcast host, author, and sought-after suicide prevention and mental health speaker, but he wouldn't be any of those things today if he hadn't been committed to a psychiatric hospital in 2003.Gabe also hosts Healthline's Inside Mental Health podcast has appeared in numerous publications, including Bipolar magazine, WebMD, Newsweek, and the Stanford Online Medical Journal. He has appeared on all four major TV networks, ABC, NBC, CBS, and FOX. Among his many awards, he is the recipient of Mental Health America's Norman Guitry Award, received two Webby Honoree acknowledgements, and received an official resolution from the Governor of Ohio naming him an “Everyday Hero.” Gabe wrote the popular book, "Mental Illness is an Asshole and other Observations," available from Amazon; signed copies are available directly from the author with free swag included! To learn more about Gabe, or to book him for your next event, please visit his website, gabehoward.com. Our host, Dr. Nicole Washington, is a native of Baton Rouge, Louisiana, where she attended Southern University and A&M College. After receiving her BS degree, she moved to Tulsa, Oklahoma to enroll in the Oklahoma State University College of Osteopathic Medicine. She completed a residency in psychiatry at the University of Oklahoma in Tulsa. Since completing her residency training, Dr. Nicole has spent most of her career caring for and being an advocate for those who are not typically consumers of mental health services, namely underserved communities, those with severe mental health conditions, and high performing professionals. Through her private practice, podcast, speaking, and writing, she seeks to provide education to decrease the stigma associated with psychiatric conditions. Find out more at DrNicolePsych.com. Learn more about your ad choices. Visit megaphone.fm/adchoices
From the earliest days of the COVID-19 pandemic, people living with MS have been justifiably concerned about how a COVID-19 infection might impact their MS. As the new "Stratus" strain of COVID-19 is currently surging in the United States, research is providing answers we didn't have five years ago. Dr. Robert Fox, the Managing Director of the NARCOMS Patient Registry, joins me to discuss how COVID-19 infections and other infections impact people with MS. As ECTRIMS, the world's largest MS research conference, approached, many attendees anticipated the FDA's decision on whether to approve Tolebrutinib, the first in a new category of disease-modifying therapies. Instead, the FDA has requested additional time for its review. We'll fill you in on the FDA's new target action date, and explain why there's strong interest in this particular disease-modifying therapy. We know there's a specific gene that increases the risk of someone developing MS. But have you ever wondered where that gene came from, or why it exists at all? At ECTRIMS, Professor Lars Fugger took us on a journey 5,000 years into the past to explain its origin. When I spoke with him, Professor Fugger also explained how events from ancient history are still affecting the risk of developing MS today. You won't want to miss this compelling conversation! At ECTRIMS, I also caught up with Jason Tardio, the President, and Dr. Andreas Muehler, the Chief Medical Officer, from Immunic Therapeutics. We talked about how their investigative drug, vidofludimus calcium, could potentially benefit people with MS by combating inflammation, protecting the nervous system, and offering antiviral benefits. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Infections and MS, and more from ECTRIMS 2025! :22 FDA extends its review of Tolebrutinib 1:42 From ECTRIMS: Professor Lars Fugger discusses the origin of the gene that increases an individual's risk of developing MS 4:11 From ECTRIMS: Jason Tardio, President, and Dr. Andreas Muehler, Chief Medical Officer, at Immunic Therapeutics, discuss how vidofludimus calcium could potentially benefit people with MS 11:22 Dr. Robert Fox discusses what the research reveals about how COVID-19 infections and other infections impact people living with MS 16:34 Share this episode 32:00 Next week's episode 32:19 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/423 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com PARTICIPATE: Take the Shaping Tomorrow Together Survey https://s.alchemer.com/s3/Perspectives-on-MS REGISTER: Attend the virtual Shaping Tomorrow Together meeting with the FDA https://nmss.quorum.us/event/25463 SIGN UP: Become an MS Activist https://nationalmssociety.org/advocacy JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms DOWNLOAD: The RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 DOWNLOAD: The RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 423 Guests: Professor Lars Fugger, Jason Tardio, Dr. Andreas Meuhler, and Dr. Robert Fox Privacy Policy
Essential oils are concentrated plant extracts obtained through distillation and pressing. This process captures the aromatic compounds responsible for the oils' fragrance and therapeutic effects The U.S. Food and Drug Administration (FDA) designates some oils as Generally Recognized as Safe (GRAS), meaning food-grade oils are safe to ingest in tiny amounts GRAS essential oils like peppermint, lemon, ginger, cinnamon, and basil can be used to flavor foods and beverages. This reflects their culinary value when used sparingly Other essential oils, such as lavender, eucalyptus, tea tree, rosemary, chamomile, wintergreen, and camphor, are best suited for aromatic or topical use Whether in food, through scent, or applied to the skin, essential oils support wellness when used with care and intention
On this episode of Vitality Radio, Jared sits down with Dr. Jason Klop, founder of Novel Biome, to explore one of the most fascinating and misunderstood frontiers in health: fecal microbiota transplant (FMT). Often misnamed “fecal matter transplant,” FMT is a highly purified process that restores microbial diversity in the gut—far beyond what probiotics alone can achieve. Jared and Dr. Klop discuss why FMT is gaining traction in digestive health, neurological conditions, and immune balance, and how it differs from traditional probiotic supplementation. You'll learn about the rigorous donor screening process, oral vs. rectal delivery methods, and why gut microbiome diversity is critical for overall vitality. The potential applications of FMT are broad and promising. This conversation pulls back the curtain on how supporting the gut ecosystem could impact everything from digestion and inflammation to mood and longevity.Additional Information:Novel BiomeNovel Biome - InstagramPodcast – Biome Breakthroughs (Spotify): Listen hereVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
I had such a powerful and eye-opening conversation with Lisa Curtis, Founder & CEO of Kuli Kuli Foods. Lisa shared her incredible journey that began in the Peace Corps in Niger, where she first discovered moringa, a nutrient-packed “tree leaf” that transformed her health. What started as a simple act of self-care in a rural village has grown into Kuli Kuli Foods, a pioneering superfoods brand that now partners with thousands of small farmers across Africa and India, empowers women, and brings nutritious, climate-smart foods to shelves nationwide. Lisa opened up about the early hurdles, navigating FDA approvals, raising money through crowdfunding, and hustling at farmers' markets, and how those small proof points led to partnerships with Whole Foods, Walmart, and more. We also explored the resilience it takes to keep going for over 12 years, her gratitude practice, and the leadership lessons that continue to guide her. This episode is packed with inspiration for entrepreneurs and food lovers alike. Here are some highlights from our conversation: How a Peace Corps experience in Niger led to the discovery of moringa and sparked the founding of Kuli Kuli Foods. Overcoming early supply chain and regulatory challenges, including a $70,000 FDA hurdle with creativity and mentorship. The role of farmers' markets and crowdfunding in proving demand and landing Whole Foods as their first big customer. Building impact by partnering with 3,000 small farmers and reinvesting 10% of profits into community projects worldwide. Lisa's advice for entrepreneurs: map out small proof points, celebrate wins, and keep the courage to start and persist. Join me, Ramon Vela, as I listen to Lisa's inspiring story of grit, gratitude, and global impact, and to discover how Kuli Kuli is changing the way we think about superfoods. For more on Kuli Kuli Foods, visit: https://www.kulikulifoods.com/ If you enjoyed this episode, please leave The Story of a Brand Show a rating and review. Plus, don't forget to follow us on Apple and Spotify. Your support helps us bring you more content like this! * Today's Sponsors: REViVE Amazon Marketing Partners: https://revivemp.com/ REViVE Amazon Marketing Partners helps better-for-you CPG brands win on Amazon with niche expertise, founder-led strategy, and a true partnership model. Built by a CPG founder with a successful exit, REViVE only works with brands it believes in. Are you curious if Amazon is right for you? Book a Free Deep Dive Strategy Session today. Workspace6 - Private Community for 7, 8, 9-figure Brands: https://www.workspace6.io/ Workspace6 is a private community where over 950 seven-, eight-, and nine-figure brand operators share insights, solve problems, and accelerate growth. It's the anti-fluff operator's room, and for your first 30 days, it's just $1. Get real answers and skip the trial and error.
This episode is sponsored by BetterHelp. Give online therapy a try at BetterHelp. Give online therapy a try at https://betterhelp.com/damagereport and get on your way to being your best self. A Republican candidate allegedly posted Nazi-themed porn. Trump's former spiritual advisor pleads guilty to child sexual assault. Americans are blaming republicans for the shutdown. ICE is using a new tool to watch millions of people. Conservatives are furious with the FDA. MAGA slams a Charlie Kirk protege after a private jet video emerges Host: John Iadarola (@johniadarola) Co-Host: Brett Erlich (@bretterlich) ***** SUBSCRIBE on YOUTUBE TIKTOK ☞ https://www.tiktok.com/@thedamagereport INSTAGRAM ☞ https://www.instagram.com/thedamagereport TWITTER ☞ https://twitter.com/TheDamageReport FACEBOOK ☞ https://www.facebook.com/TheDamageReportTYT
SPONSOR: RELIEFBAND - If you deal with nausea, Reliefband is a breakthrough you need to know about. It’s the original anti-nausea wristband that quickly relieves and effectively prevents nausea and vomiting, without the use of drugs or drowsy side effects. You simply wear it on your wrist, adjust the intensity depending on how you’re feeling, and within minutes, it starts working. The new Premier Plus model even includes a digital clock and smart skin-sensing technology to help preserve battery life. It’s FDA-cleared technology originally developed for hospital use.So, if you want to cure your nausea problem FAST, join the hundreds of thousands of people who are nausea-free with Reliefband. Right now, there’s an exclusive offer just for listeners of the Rick Burgess Show. If you go to http://www.Reliefband.com and use promo code “RICKB” you’ll receive 20% off, plus free shipping!See omnystudio.com/listener for privacy information.
SPONSOR: RELIEFBAND - If you deal with nausea, Reliefband is a breakthrough you need to know about. It’s the original anti-nausea wristband that quickly relieves and effectively prevents nausea and vomiting, without the use of drugs or drowsy side effects. You simply wear it on your wrist, adjust the intensity depending on how you’re feeling, and within minutes, it starts working. The new Premier Plus model even includes a digital clock and smart skin-sensing technology to help preserve battery life. It’s FDA-cleared technology originally developed for hospital use. So, if you want to cure your nausea problem FAST, join the hundreds of thousands of people who are nausea-free with Reliefband. Right now, there’s an exclusive offer just for listeners of the Rick Burgess Show. If you go to http://www.Reliefband.com and use promo code “RICKB” you’ll receive 20% off, plus free shipping!See omnystudio.com/listener for privacy information.
Today's Headlines: President Trump has formally declared the U.S. to be in an “armed conflict” with drug cartels, invoking war powers and ordering military strikes on Caribbean boats the administration labels as “terrorist organizations.” Lawmakers in both parties are skeptical of the legal basis but—shocker—seem unlikely to act. Meanwhile, the government shutdown has left 750,000 workers unpaid or furloughed, and the White House is now threatening permanent firings with help from Project 2025 architect Russell Vought. Shutdown propaganda even seeped into federal employees' auto-replies, which were forcibly edited to blame Democrats. The Energy Department axed $7.6 billion in clean energy grants, conveniently targeting states that voted for Kamala Harris. The administration also sent nine universities—including Vanderbilt, MIT, and Brown—a “compact” demanding they overhaul admissions, freeze tuition, and abolish certain departments in exchange for federal funds. Elsewhere, the FDA approved a generic version of the abortion pill mifepristone, sparking predictable outrage despite it being a routine process. Yom Kippur was marred by a deadly terror attack at a synagogue in Manchester, where two worshippers were killed and the attacker was shot dead. And finally, Commerce Secretary Howard “Laughin'” Lutnick, a former neighbor of Jeffrey Epstein, suggested Epstein blackmailed powerful men with videos, casually detonating months of damage control efforts with a single podcast appearance. Resources/Articles mentioned in this episode: AP News: Trump says US is in 'armed conflict' with drug cartels after ordering strikes in the Caribbean WSJ: Lawmakers From Both Sides Pressed Pentagon on Legal Basis for Cartel Boat Strikes Axios: Trump embraces Project 2025 after disavowing it during 2024 campaign Wired: Government Workers Say Their Out-of-Office Replies Were Forcibly Changed to Blame Democrats for Shutdown AP News: Trump administration cuts nearly $8B in clean energy projects in states that backed Harris WSJ: Exclusive | Trump White House Asks Colleges to Sign Sweeping Agreement to Get Funding Advantage AP News: FDA approves another generic abortion pill, prompting outrage from conservatives Reuters: Synagogue attack on Yom Kippur kills two in UK's Manchester; suspect shot dead ABC News: Howard Lutnick believes Jeffrey Epstein may have used blackmail to get a lighter sentence Morning Announcements is produced by Sami Sage and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices
The news to know for Friday, October 3, 2025! We'll tell you where President Trump is promising to make permanent cuts during this government shutdown. Also, we're talking about a new notice telling Congress the U.S. is at war with drug cartels. And the backlash over a new abortion pill that just got the FDA's approval. Plus: the latest records broken on Wall Street, the reason many conservatives are quitting Netflix, and the frenzy over Taylor Swift's newest album that came out overnight. Those stories and even more news to know in about 10 minutes! Join us every Mon-Fri for more daily news roundups! See sources: https://www.theNewsWorthy.com/shownotes Become an INSIDER to get AD-FREE episodes here: https://www.theNewsWorthy.com/insider Sign-up for our Friday EMAIL here: https://www.theNewsWorthy.com/email Get The NewsWorthy MERCH here: https://thenewsworthy.dashery.com/ Sponsors: Get 50% off 1 month of Trade at drinktrade.com/newsworthy Save 25% on your first month of a Dose subscription by going to dosedaily.co/NEWSWORTHY or entering NEWSWORTHY at checkout. To advertise on our podcast, please reach out to ad-sales@libsyn.com
Our China Healthcare Analyst Jack Lin discusses how China's biotech surge is reshaping healthcare, investment and innovation worldwide.Read more insights from Morgan Stanley.----- Transcript ----- Jack Lin: Welcome to Thoughts on the Market. I'm Jack Lin, from Morgan Stanley's China Healthcare Team. Today, the boom in China biotech – and how it's not just a headline for China-focused investors, but a story that touches all of us. It is Friday, October 3rd at 2pm in Hong Kong. Many people might not realize this but some of the next generation healthcare innovation is being developed far from Silicon Valley and Wall Street. The medicines you rely on, treatment plans that could shape your family's future, even investment opportunity that can grow your savings. They are all increasingly influenced by China's rapidly evolving biotech sector, which is transitioning from traditional generics manufacturing into the global innovation ecosystem. In fact, China's biotech industry is set to become a major player in the global innovation ecosystem. By 2040, we project China's originated assets could represent about a third of U.S. FDA approvals – up dramatically from just 5 percent today. And the question isn't if China's biotech will matter, but how global patients could benefit; and how consumers and investors worldwide might engage with its impact.What's driving this transformation? Three key components are driving the globalization of China originated drug innovations: cost, accessibility, and innovation quality. Lower cost in China's biotech sector enables more efficient development. Clinical trial quality is improving with regulatory pathways becoming more streamlined, promoting accessibility of China innovation for global markets. Finally, innovation in China's biotech sector is gaining momentum with more regionally developed medicines now eyeing market approval from leading overseas agencies like the U.S. FDA and EMA.This is all to say China is on track to become a key force on the global biotech stage. That said, right now we're also at a crossroads moment as geopolitical tensions between U.S. and China pose potential risks to the flow of innovation. Despite these uncertainties, we see a likely outcome of co-opetition, a blend of competition and collaboration, as global pharma grapples with the dual imperatives of innovation and resilience. Of course, this rapid evolution brings both opportunities and challenges. It's prompting stakeholders around the world to rethink their strategies and collaborations in this shifting landscape of global medical innovation. As the China biotech industry evolves, the choices made by investors, policy makers, and healthcare communities, both within China and globally, will determine the therapies of the future. It is truly a dynamic space, and we'll continue to bring you updates. Thanks for listening to our thoughts on the market. If you enjoy the show, please leave us a review, wherever you listen and share Thoughts on the Market with a friend or colleagues today.
Aaron McIntire dives into the week's top stories on The A.M. Update, covering the government shutdown debate, Democrats' push for healthcare for illegal immigrants, a shocking anti-Semitic attack in the UK, more on that bizarre Iowa superintendent case, and the FDA's approval of a generic abortion pill. Plus, listener questions in Ask or Tell Me Anything tackle military leadership, church engagement, and eschatology. government shutdown, immigration, healthcare, anti-Semitism, UK attack, Iowa superintendent, abortion pill, FDA, Project 2025, Trump, listener questions,
The federal government has frozen funds to another Democrat run city as the government shutdown continues. Sean “Diddy” Combs is set for a lengthy sentencing hearing today. President Donald Trump has given a stark ultimatum to Hamas over his Gaza peace proposal. The shutdown has stopped the jobs report coming out today, but other data has given an estimate on job numbers. Plus, why abortion opponents are angry at the FDA. Learn more about your ad choices. Visit podcastchoices.com/adchoices
D.C. insider Tom McClusky takes us behind the scenes of the government shutdown—what's really happening in Washington? Meanwhile, the FDA approves a new abortion drug, sparking outrage and debate. And finally, Erika gives her take on Pope Leo's ice block blessing. All this and more on the LOOPcast!00:00 Welcome to the LOOPcast 02:00 Nazareth Organics04:18 GOV Shutdown Day 3 Update 20:02 Home Title Lock27:54 Good News39:20 Gaza Peace Plan1:00:00 Twilight Zone1:09:45 Closing PrayerNazareth Organics is a Catholic family-owned natural skincare company that handcrafts tallow balms and serums with high-quality, wild-crafted, and organic ingredients. Find them at https://nazareth-organics.com and use code LOOPCAST at checkout for a 10% discount. Follow them on Instagram and Facebook at: @nazarethorganicsProtect your equity with Home Title Lock's exclusive Million Dollar Triple Lock Protection, now for just $1 for 60 days when you use promocode LOOP60! Click here: https://www.hometitlelock.com/looper to learn more!EMAIL US: loopcast@catholicvote.org SUPPORT LOOPCAST: www.loopcast.orgSubscribe to the LOOP today!https://catholicvote.org/getloop Apple Podcasts: https://podcasts.apple.com/us/podcast/the-loopcast/id1643967065 Spotify: https://open.spotify.com/show/08jykZi86H7jKNFLbSesjk?si=ztBTHenFR-6VuegOlklE_w&nd=1&dlsi=bddf79da68c34744 FOLLOW LOOPCast: https://x.com/the_LOOPcast Tom: https://x.com/TPogasic Erika: https://x.com/ErikaAhern2 Josh: https://x.com/joshuamercer All opinions expressed on LOOPcast by the participants are their own and do not necessarily reflect the opinions of CatholicVote.
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sanofi lowers prices, oral pill for T1D prevention studied, updates from Medtronic, Tandem, and Sequel Med Tech, falsely lower A1Cs (and why that happens), Biolinq gets FDA okay for micro-needle CGM and more! Find out more about Moms' Night Out Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX French drugmaker Sanofi says it would offer a month's supply of any of its insulin products for $35 to all patients in the U.S. with a valid prescription, regardless of insurance status. The program, originally meant for uninsured diabetes patients, would now include those with commercial insurance or Medicare, the drugmaker said. Patients will be able to purchase any combination, type, and quantity of Sanofi insulins with a valid prescription for the fixed monthly price of $35, starting January 1. Lilly and Novo also have similar programs through which they offer insulin products for $35 a month for U.S. patients regardless of whether the patients have insurance. There is no law at work here – the only legislation that has changed the price of insulin came with the Inflation Reduction Act in 2022 with the Medicare cap. Helping lower the cost here, biosimilars hitting the market and the huge profitability for GLP-1 drugs for Novo and Lilly https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-offer-all-insulin-products-35-per-month-us-2025-09-26/ XX A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, a new study says. Baricitinib (bare-uh-SIT-nib) safely preserved the body's own insulin production in people newly diagnosed with type 1 diabetes.. and their diabetes started progressing once they stopped taking baricitinib, results show. They produced less insulin and had less stable blood sugar levels. Baricitinib works by quelling signals in the body that spur on the immune system, and is already approved for treating autoimmune conditions such as rheumatoid arthritis, ulcerative colitis and alopecia, researchers said. “Among the promising agents shown to preserve beta cell function in type 1 diabetes, baricitinib stands out because it can be taken orally, is well tolerated, including by young children, and is clearly efficacious,” Waibel said. “We are hopeful that larger phase III trials with baricitinib are going to commence soon, in people with recently diagnosed type 1 diabetes as well as in earlier stages to delay insulin dependence,” she added. “If these trials are successful, the drug could be approved for type 1 diabetes treatment within five years.” Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal. https://www.usnews.com/news/health-news/articles/2025-09-23/pill-effective-in-slowing-type-1-diabetes-progression XX An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease after diagnosis. The Drug, called ATG, is currently used together with other medicines to prevent and treat the body from rejecting a kidney transplant. It can also be used to treat rejection following transplantation of other organs, such as hearts, gastrointestinal organs, or lungs. The researchers studied 117 people aged five to 25, who'd been diagnosed with type 1 diabetes within the past three to nine weeks. The participants were from 14 centers across eight European countries and were randomized to be given different doses of ATG (0.1, 0.5, 1.5, or 2.5 mg/kg) or a placebo. ATG was given as a two-day intravenous (IV) infusion. The main goal was to see how well the pancreas could still make insulin after 12 months, measured by C-peptide levels during a special meal test. C-peptide is released into the blood along with insulin by the pancreas. The findings are promising, showing that ATG, even at a relatively low dose, can slow the loss of insulin-producing cells in young people newly diagnosed with type 1 diabetes. The lower dose also caused fewer side effects, making it a more practical option. https://newatlas.com/disease/antithymocyte-globulin-newly-diagnosed-type-1-diabetes/ XX The FDA has delayed its feedback on Lexicon Pharmaceuticals' application to bring Zynquista (sotagliflozin) to people with type 1 diabetes. The agency had planned to respond this month but will now wait until the fourth quarter after reviewing new data from ongoing studies. Zynquista, an oral drug meant to be used with insulin, has already been approved for heart failure (marketed as Inpefa). But in type 1 diabetes, it faces safety concerns: last year an FDA advisory committee voted 11–3 that its benefits don't outweigh the increased risk of diabetic ketoacidosis (DKA). The FDA later issued a complete response letter rejecting the drug. Lexicon is still pushing forward, hoping its additional submissions will strengthen Zynquista's case for type 1 diabetes approval. https://www.biospace.com/fda/after-fda-rejection-lexicons-type-1-diabetes-drug-hit-with-another-regulatory-delay XX A common but often undiagnosed genetic condition may be causing delays in type 2 diabetes diagnoses and increasing the risk of serious complications for thousands of Black and South Asian men in the UK—and potentially millions worldwide. A new study found around one in seven Black and one in 63 South Asian men in the UK carry a genetic variant known as G6PD deficiency. Men with G6PD deficiency are, on average, diagnosed with type 2 diabetes four years later than those without the gene variant. But despite this, fewer than one in 50 have been diagnosed with the condition. G6PD deficiency does not cause diabetes, but it makes the widely used HbA1c blood test—which diagnoses and monitors diabetes—appear artificially low. This can mislead doctors and patients, resulting in delayed diabetes diagnosis and treatment. The study found men with G6PD deficiency are at a 37% higher risk of developing diabetes-related microvascular complications, such as eye, kidney, and nerve damage, compared to other men with diabetes. "This study highlights important evidence that must be used to tackle these health inequalities and improve outcomes for Black communities. Preventative measures are now needed to ensure that Black people, especially men, are not underdiagnosed or diagnosed too late." https://medicalxpress.com/news/2025-09-hidden-genetic-delay-diabetes-diagnosis.html XX Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a once-weekly basal insulin treatment for adults living with type 2 diabetes. If approved, Awiqli® would become the first once-weekly basal insulin available in the United States, providing an alternative to daily basal insulin injections for adults living with type 2 diabetes. The resubmission is based on results from the ONWARDS type 2 diabetes phase 3a program for once-weekly Awiqli® which is comprised of five randomized, active-controlled, treat-to-target clinical trials in approximately 4,000 adults with type 2 diabetes. The clinical program evaluated Awiqli® vs. daily basal insulin and the primary endpoint in these trials was change in A1C from baseline.1-5 Awiqli® is approved in the EU, along with 12 additional countries. In addition, regulatory filings have been completed in several other countries, with further regulatory decisions expected in 2025. XX Interesting news from Sequel Med Tech – they've signed an agreement with Arecor to pair the twiist pump with AT278 an ultra-concentrated (500U/mL), ultra-rapid insulin in development. They also have a deal with Medtronic to develop insulin for new pumps. This insulin isn't yet approved, it's 5 times stronger than standard fast acting it's hoped that a clinical study will begin next year. Arecor says its insulin could potentially be the only option capable of enabling and catalyzing the next generation of longer-wear and miniaturized automated insulin delivery systems. https://www.drugdeliverybusiness.com/sequel-arecor-develop-rapid-insulin-twiist/ XX Tandem Diabetes Care announes its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company's Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the United States (U.S.). – The t:slim X2 insulin pump with Control-IQ+ technology is now cleared for use with Lyumjev for people with type 1 diabetes ages 2 and above and all adults with type 2 diabetes. The companies are continuing to work toward securing Lyumjev compatibility for the Tandem Mobi pump. https://hitconsultant.net/2025/09/29/tandem-diabetes-cares-tslim-x2-pump-cleared-for-use-with-lillys-ultra-rapid-lyumjev-insulin/ XX You can now place your order for the MiniMed™ 780G system with the Instinct sensor, made by Abbott. And if you are already a MiniMed 780G user, you can place an upgrade order today. This is a 15 day wear sensor, with no transmitter or overtape required. It looks the same at other Abbot sensors such as the Libre but is proprietary to Medtronic. Shipments are scheduled to start in November. https://www.drugdeliverybusiness.com/medtronic-launches-minimed-780g-instinct-abbott/ XX The global type 1 diabetes (T1D) burden continues to increase rapidly driven by rising cases, ageing populations, improved diagnosis and falling death rates. , The study estimates that T1D will affect 9.5 million people globally in 2025 (up by 13% since 2021), and this number is predicted to rise to 14.7 million in 2040. However, due to lack of diagnosis and challenges in collecting sufficient data, the actual number of individuals living with T1D is likely much higher, researchers say. In fact, they estimate that there are an additional 4.1 million 'missing people' who would have been alive in 2025 if they hadn't died prematurely from poor T1D care, including an estimated 669,000 who were not diagnosed. This is particularly true in India, where an estimated 159,000 people thought to have died from missed diagnoses. The study predicts that 513,000 new cases of T1D will be diagnosed worldwide in 2025, of which 43% (222,000) will be people younger than 20 years old. Finland is projected to have the highest incidence of T1D in children aged 0-14 years in 2025 at around 64 cases per 100,000. The substantial increases in T1D forecasts between 2025 and 2040 underscore the urgent need for action. As co-author Renza Scibilia from Breakthrough T1D explains, "Early diagnosis, access to insulin and diabetes supplies, and proper healthcare can bring enormous benefits, with the potential to save millions of lives in the coming decades by ensuring universal access to insulin and improving the rate of diagnosis in all countries." The authors note some important limitations to their estimates, including that while the analysis uses the best available data, predictions are constrained by the lack of accurate data in most countries-highlighting the urgent need for increased surveillance and research. They also note that data on misdiagnosis and adult populations remain limited, and the analysis assumes constant age-specific incidence and mortality over time. Furthermore, incidence data from the COVID-19 period were excluded from part of the modelling to avoid bias. Future updates are expected to improve as new data become available and applied. https://www.news-medical.net/news/20250919/New-study-warns-of-millions-of-undiagnosed-and-missing-people-with-type-1-diabetes.aspx XX A new study has found that semaglutide — the active ingredient found in some GLP-1 medications prescribed for diabetes and to aid weight loss — may help protect the eyes from diabetic retinopathy. Researchers estimate that as much as 40% of all people with diabetes also have diabetic retinopathy — a potentially blinding eye condition caused by blood vessel damage in the eye's retina. There is currently no cure for diabetic retinopathy. The condition is often managed through injections of anti-VEGF medications into the eye, surgery, and blood sugar monitoring and control. For this lab-based study, researchers used samples of human retinal endothelial cells that were treated with different concentrations of semaglutide. The cells were then placed in a solution with both a high glucose level and high level of oxidative stress — where there is an imbalance of antioxidants and free radicals — for 24 hours. Past studies show that oxidative stress plays a role in the formation of diabetic retinopathy. At the study's conclusion, researchers found that the retinal cells treated with semaglutide were twice as likely to survive than cells that were untreated. Additionally, the treated cells were found to have larger stores of energy. Scientists also found that three markers of diabetic retinopathy were decreased in the semaglutide-treated retinal cells. First, the levels of apoptosis — a form of cell death — decreased from about 50% in untreated cells to about 10% in semaglutide-treated cells. The production of the free radical mitochondrial superoxide decreased from about 90% to about 10% in the treated retinal cells. Researchers also found the amount of advanced glycation end-products — harmful compounds that can collect in people with diabetes and are known to cause oxidative stress — also decreased substantially. Lastly, scientists reported that the genes involved in the production of antioxidants were more active in the semaglutide-treated cells when compared to untreated cells. Researchers believe this is a sign that semaglutide may help repair damage to the retinal cells. “Our study did not find that these drugs harmed the retinal cells in any way — instead, it suggests that GLP1-receptor agonists protect against diabetic retinopathy, particularly in the early stages,” Ioanna Anastasiou, PhD, molecular biologist and postdoctoral researcher at the National and Kapodistrian University in Greece, and lead author of this study, said in a press release. “Excitingly, these drugs may be able to repair damage that has already been done and so improve sight. Clinical trials are now needed to confirm these protective effects in patients and explore whether GLP-1 receptor agonists can slow, or even halt, the progression of this vision-robbing condition.” https://www.medicalnewstoday.com/articles/ozempic-semaglutide-may-help-protect-against-diabetes-related-blindness-retinopathy XX Biolinq has received De Novo Classification from the U.S. Food and Drug Administration for its lead product, Biolinq Shine, a patch on the forearm that provides real-time glucose feedback through a primary color-coded LED display, visible with or without a phone. This one is tricky – it's called a needle free CGM but it also says it uses micro needles. By the way, De Novo isn't exactly the same as what we think of for FDA approval for medical devices. It's not as rigorous but it's a streamlined route for novel, low to moderate risk devices with no existing equivalent. We'll see how this one turns out. https://www.hmenews.com/article/biolinq-s-multi-function-biosensor-receives-fda-de-novo-classification
The Republican-run government has shut down, Trump is using misinformation to blame Democrats, and Erin and Alyssa explain what's at stake. Then they dive into Ezra Klein's recent bad takeapalooza, on everything from Charlie Kirk's legacy to pro-life Democrats. And, of course, there's the latest Epstein files news, some races to watch in Virginia, and a big week for creeps, overall. They wrap up in the Sanity Corner with a discussion about their excitement for Aaron Sorkin's The Social Reckoning and a petty roast of Ivanka Trump's Instagram. Explaining the G.O.P.'s Misleading Talking Point on the Looming Shutdown (NYT 9/29)Ta-Nehisi Coates on Bridging Gaps vs. Drawing Lines (NYT 9/28)RFK Jr. launches FDA review of abortion pill (ABC News 9/24)Musk, Thiel and Bannon named in Epstein docs released by Dems (Axios 9/26)Elon Musk's Father Accused of Child Sexual Abuse (NYT 9/25)Money manager Howard Rubin detained in sex trafficking case after feds cite hitman threat (CNBC 9/26)Ryan Walters steps down as Oklahoma schools chief to lead anti-teachers union group (The 19th News 9/26)The State of Our Nation: Gauging Americans' political opinions in 2025 (The 19th* 9/25) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Abdul and Katelyn discuss the latest news in public health, which includes: Trump's $100,000 H1-B visa fee, which is could significantly hurt staffing in rural hospitals A new 100% tariff on certain imported brand-name drugs RFK Jr's announcement that the FDA is re-evaluating the abortion medication mifepristone A new scientific breakthrough that's giving hope to people with Huntington's Disease Then Abdul sits down with Dr. Aziz Rahman, an American physician who recently completed a medical mission in Gaza. Dr. Rahman offers a gripping account of the devastation in Gaza, and the heroic efforts of doctors serving there. Check out our shop at store.americadissected.com for our new America Dissected merch – including logo shirts, hoodies and mugs. And don't miss our “Vaccines Work. Science Matters.” t-shirts! This show would not be possible without the generous support of our sponsors. America Dissected invites you to check them out. This episode was brought to you by: Boll & Branch: For a limited time get 20% off your first set of sheets plus free shipping at BollAndBranch.com/AD. Quince: Go to Quince.com/AD for free shipping on your order and 365-day returns. APHA: Listeners of this podcast get a 10% discount for the 2025 Annual Meeting and Expo using code: Dissected25.
Dr. Mary Tally Bowden is part of a growing movement to make ivermectin available without a prescription. She talks with Sharyl about efforts to take her down for prescrbing ivermectin during Covid, and how her lawsuit proved the FDA wrong.Order Sharyl's new bestselling book: “Follow the $cience.” Subscribe to my two podcasts: “The Sharyl Attkisson Podcast” and “Full Measure After Hours.” Leave a review, subscribe and share with your friends! Support independent journalism by visiting the new Sharyl Attkisson store.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode, Darin exposes the toxic truth behind the billion-dollar anti-aging skincare industry. From mercury to PFOAs (the same chemical used in Teflon), many “miracle creams” and skin-lightening products marketed as beauty solutions are actually silently poisoning us. Darin breaks down the science, the loopholes in FDA regulation, and the real dangers of what's being absorbed through our skin — from hormone disruption to cancer and even risks to children. More importantly, he offers solutions: how to identify red flags, choose safe alternatives, and reclaim sovereignty over what you put on your body. What You'll Learn in This Episode: 00:00 – Welcome to SuperLife and the mission to live free from fatal conveniences 00:32 – The cookware sponsor shoutout and why toxic exposure starts in the kitchen 03:08 – Fatal Convenience focus: anti-aging skincare products and hidden toxins 04:39 – Why what you put on your skin is like ingesting it — the reality of transdermal absorption 05:40 – Mercury in cosmetics: how it destroys biology and hides under confusing chemical names 08:18 – PFOAs (Teflon chemicals) in skincare and why they're linked to cancer and hormone disruption 10:28 – The dangers extend beyond users — off-gassing mercury can affect families and children 11:29 – Even the FDA admits toxicity, yet products still end up on shelves 12:25 – Supplement sponsor shoutout: Manna Vitality for cellular renewal 14:20 – Mercury exposure risks for pregnant and nursing mothers, and infants 15:19 – Signs of mercury poisoning: irritability, tremors, depression, numbness 16:24 – Conflicts of interest and failures at FDA, EPA, USDA — why regulation isn't protecting you 17:26 – How to protect yourself: avoid “anti-aging” and “skin-lightening” labels, and do due diligence 18:20 – Brands exposed for cutting corners and why demand must shift 18:55 – Choosing botanical, organic, chemical-free products as the true path to health 19:26 – Final reminder: don't buy into marketing that preys on insecurity — sovereignty starts with awareness Thank You to Our Sponsors Our Place: Toxic-free, durable cookware that supports healthy cooking. Use code DARIN for 10% off at fromourplace.com. Manna Vitality: Go to mannavitality.com/ or use code DARIN20 for 20% off your order. Find More from Darin Olien: Instagram: @darinolien Podcast: SuperLife Podcast Website: superlife.com Book: Fatal Conveniences Key Takeaway “If you wouldn't eat it, don't put it on your skin. Mercury, PFOAs, and toxic chemicals in anti-aging creams are poisoning us — but when we choose botanical, organic, and safe alternatives, we reclaim our health and our sovereignty.”
What if the vision problems you'll face in your 70s are actually being determined by the choices you're making right now? We're constantly damaging our eyes without even realising it, through screen exposure, UV radiation, and nutritional deficiencies that silently accumulate over decades. The good news is, the FDA has approved its first-ever dry macular degeneration treatment in 2024, which reduces vision loss risk by 25%. Bonus: I'll also cover innovative therapies, essential nutrition, and lifestyle activities that can boost your eye health and prevent eye problems later on! Join the Ultimate Human VIP community for Gary Brecka's proven wellness protocols! https://bit.ly/4ai0Xwg Thank you to our partners H2TABS: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4hMNdgg BODYHEALTH: “ULTIMATE20” FOR 20% OFF: http://bit.ly/4e5IjsV BAJA GOLD: "ULTIMATE10" FOR 10% OFF: https://bit.ly/3WSBqUa EIGHT SLEEP: SAVE $350 ON THE POD 4 ULTRA WITH CODE “GARY”: https://bit.ly/3WkLd6E COLD LIFE: THE ULTIMATE HUMAN PLUNGE: https://bit.ly/4eULUKp WHOOP: JOIN AND GET 1 FREE MONTH!: https://bit.ly/3VQ0nzW MASA CHIPS: 20% OFF FIRST ORDER: https://bit.ly/40LVY4y VANDY: “ULTIMATE20” FOR 20% OFF: https://bit.ly/49Qr7WE AION: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4h6KHAD A-GAME: “ULTIMATE15” FOR 15% OFF: http://bit.ly/4kek1ij CARAWAY: “ULTIMATE” FOR 10% OFF: https://bit.ly/3Q1VmkC HEALF: 10% OFF YOUR ORDER: https://bit.ly/41HJg6S BIOPTIMIZERS: “ULTIMATE” FOR 15% OFF: https://bit.ly/4inFfd7 RHO NUTRITION: “ULTIMATE15” FOR 15% OFF: https://bit.ly/44fFza0 GOPUFF: GET YOUR FAVORITE SNACK!: https://bit.ly/4obIFDC GENETIC TEST: https://bit.ly/3Yg1Uk9 Watch the “Ultimate Human Podcast” every Tuesday & Thursday at 9AM EST: YouTube: https://bit.ly/3RPQYX8 Podcasts: https://bit.ly/3RQftU0 Connect with Gary Brecka Instagram: https://bit.ly/3RPpnFs TikTok: https://bit.ly/4coJ8fo X: https://bit.ly/3Opc8tf Facebook: https://bit.ly/464VA1H LinkedIn: https://bit.ly/4hH7Ri2 Website: https://bit.ly/4eLDbdU Merch: https://bit.ly/4aBpOM1 Newsletter: https://bit.ly/47ejrws Ask Gary: https://bit.ly/3PEAJuG Timestamps 00:00 Intro of Show 01:39 Latest Research on Vision Protection 02:24 How to Treat Dry Macular Degeneration 04:12 Laser Therapy for Glaucoma 06:15 Red Light Therapy for Dry Eyes 06:21 Essential Nutrients for Eye Health 10:11 Lifestyle Activities for Eye Health 12:49 Free Water Fasting Challenge The Ultimate Human with Gary Brecka Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The Content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Learn more about your ad choices. Visit megaphone.fm/adchoices
Obesity is often seen as a matter of willpower, but science tells a different story. My guest today, Dr. David Kessler—former FDA commissioner, lawyer, physician, and the man who took on Big Tobacco—explains why biology, not blame, drives our struggles with weight. On this episode of The Dr. Hyman Show, we talk about why weight struggles are so common today, what new drugs can and can't do, and how his new FDA petition targets one of the biggest culprits: processed refined carbs. Catch the full conversation on YouTube, or listen wherever you get your podcasts. [YOUTUBE THUMBNAIL] You'll learn: • How food companies use ingredients like processed refined carbs to make products irresistible • Why GLP-1 drugs help many lose weight—but can't fix the food environment driving the crisis • How belly fat fuels heart disease, diabetes, and cancer—and why ultraprocessed foods are a big part of the problem • Simple ways to break free from foods engineered to make you overeat • What Dr. Kessler's FDA petition could mean for limiting processed carbs in our food supply and improving our collective health Plus, here's a bonus: We've adapted Dr. Kelsser's petition into a free PDF guide—The Hard Truth About Processed Carbs—so you can see exactly how these ingredients affect your health…and why his FDA petition REALLY matters. Tune in, download the guide, and find out how you can be part of the solution. View Show Notes From This Episode Get Free Weekly Health Tips from Dr. Hyman https://drhyman.com/pages/picks?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Sign Up for Dr. Hyman's Weekly Longevity Journal https://drhyman.com/pages/longevity?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Join the 10-Day Detox to Reset Your Health https://drhyman.com/pages/10-day-detox Join the Hyman Hive for Expert Support and Real Results https://drhyman.com/pages/hyman-hive This episode is brought to you by Seed, Paleovalley, Function Health, Timeline and AirDoctor. Visit seed.com/hyman and use code 25HYMAN for 25% off your first month of Seed's DS-01® Daily Synbiotic. Get nutrient-dense, whole foods. Head to paleovalley.com/hyman for 15% off your first purchase. Join today at FunctionHealth.com/Mark and use code HYMAN100 to get $100 toward your membership. Support essential mitochondrial health and save 20% on Mitopure. Visit timeline.com/drhyman to get 20% off today. Get cleaner air. Right now, you can get up to $300 off at airdoctorpro.com/drhyman.
© 2020-2025 Ivy Podcast Discovery LLC
